Ignite Creation Date:
2025-12-25 @ 3:18 AM
Ignite Modification Date:
2026-07-01 @ 9:31 PM
Study NCT ID:
NCT01094405
Status:
COMPLETED
Last Update Posted:
2021-07-28
First Post:
2010-03-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy
Sponsor:
Chinese University of Hong Kong
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
VAC003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None